Cytochromes P450 et formation de métabolites réactifs : rôle dans l'hépatotoxicité des médicaments = Cytochrome P450 and formation of reactive metabolites. Role in drug-induced hepatotoxicityPESSAYRE, D.Thérapie (Paris). 1993, Vol 48, Num 6, pp 537-548, issn 0040-5957Conference Paper

HEPATITES MEDICAMENTEUSES DUES A DES METABOLITES INSTABLESPESSAYRE D; BENHAMOU JP.1978; PROBL. ACTUELS REANIM.; FRA; DA. 1978; PP. 17-28; BIBL. 19 REF.Article

LES HEPATITES DUES AUX ANTIDEPRESSEURSDANAN G; PESSAYRE D.1982; ANNALES DE GASTROENTEROLOGIE ET D'HEPATOLOGIE; ISSN 0066-2070; FRA; DA. 1982; VOL. 18; NO 6; PP. 433-435; BIBL. 17 REF.Article

LES HEPATITES DUES A L'ASSOCIATION IONIAZIDE-RIFAMPICINEPESSAYRE D; BENHAMOU JP.1978; ENTRET. DE BICHAT, THERAPEUT.; FRA; DA. 1978; PP. 167-169; BIBL. 12 REF.Conference Paper

Physiopathologie des hépatopathies médicamenteuses = Mechanisms of drug-induced liver lesionsPESSAYRE, D.Gastroentérologie clinique et biologique. 1993, Vol 17, Num 5BIS, pp H3-H17, issn 0399-8320Article

HEPATITES MEDICAMENTEUSES DUES A DES METABOLITES INSTABLESPESSAYRE D; BENHAMOU JP.1979; LILLE MED.; FRA; DA. 1979; VOL. 24; NO 8; PP. 613-619; BIBL. 19 REF.Article

EST-IL POSSIBLE ET SOUHAITABLE DE DETECTER L'HEPATOTOXICITE D'UN MEDICAMENT AVANT SA COMMERCIALISATION.PESSAYRE D; BENHAMOU JP.1981; GASTROENTEROL. CLIN. BIOL.; ISSN 0399-8320; FRA; DA. 1981; VOL. 5; NO 5; PP. 560-563; BIBL. 14 REF.Article

HEPATITES MEDICAMENTEUSES DUES A DES METABOLITES INSTABLESPESSAYRE D; BENHAMOU JP.1978; ACTA GASTRO-ENTEROL. BELG.; BEL; DA. 1978; VOL. 41; NO 9-10; PP. 574-596; ABS. ENG/DUT; BIBL. 19 REF.Article

INDUCTION AND INHIBITION OF HEPATIC DRUG METABOLIZING ENZYMES BY RIFAMPINPESSAYRE D; MAZEL P.1976; BIOCHEM. PHARMACOL.; G.B.; DA. 1976; VOL. 25; NO 8; PP. 943-949; BIBL. 44 REF.Article

FORMATION OF INACTIVE CYTOCHROME P-450 FE(II)-METABOLITE COMPLEXES WITH SEVERAL ERYTHROMYCIN DERIVATIVES BUT NOT WITH JOSAMYCIN AND MIDECAMYCIN IN RATSLARREY D; TINEL M; PESSAYRE D et al.1983; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1983; VOL. 32; NO 9; PP. 1487-1493; BIBL. 27 REF.Article

SELF-INDUCTION BY ERYTHROMYCIN OF ITS OWN TRANSFORMATION INTO A METABOLITE FORMING AN INACTIVE COMPLEX WITH REDUCED CYTOCHROME P-450DANAN G; DESCATOIRE V; PESSAYRE D et al.1981; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1981; VOL. 218; NO 2; PP. 509-514; BIBL. 21 REF.Article

TOXICITE DUE AUX METABOLITES DITS "REACTIFS" DES MEDICAMENTS.PESSAYRE D; MAZEL P; BENHAMOU JP et al.1976; NOUV. PRESSE MED.; FR.; DA. 1976; VOL. 5; NO 18; PP. 1201-1204; BIBL. 17 REF.Article

COLLAPSUS APRES EXPLORATION ENDOVASCULAIRE: ROLE DE L'OXYDE D'ETHYLENE OU REACTION ENDOTOXINIQUE.LEBREC D; PESSAYRE D; TREVOUX A et al.1978; NOUV. PRESSE MED.; FRA; DA. 1978; VOL. 7; NO 39; PP. 3558; BIBL. 4 REF.Article

HEPATITE DUE AU PROPIONATE D'ERYTHROMYCINE.PESSAYRE D; MARIE C; BENHAMOU JP et al.1976; ARCH. FR. MAL. APPAR. DIGEST.; FR.; DA. 1976; VOL. 65; NO 5; PP. 405-408; ABS. ANGL.; BIBL. 18 REF.Article

HEPATITES DUES A DIVERS DERIVES DE L'ERYTHROMYCINEFUNCK BRENTANO C; PESSAYRE D; BENHAMOU JP et al.1983; GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE; ISSN 0399-8320; FRA; DA. 1983; VOL. 7; NO 4; PP. 362-369; BIBL. 2 P.Article

EFFECTS DES MALADIES DU FOIE, ET DES VOIES BILIAIRES SUR LE METABOLISME DES MEDICAMENTS.PESSAYRE D; ALLEMAND H; BENHAMOU JP et al.1977; NOUV. PRESSE MED.; FR.; DA. 1977; VOL. 6; NO 35; PP. 3209-3219 (7P.); ABS. ANGL.; BIBL. 66 REF.Article

DIHYDRALAZINE HEPATITIS: REPORT OF A CASE AND REVIEW OF THE LITERATUREPARIENTE EA; PESSAYRE D; BERNUAU J et al.1983; DIGESTION; ISSN 0012-2823; CHE; DA. 1983; VOL. 27; NO 1; PP. 47-52; BIBL. 13 REF.Article

DONNEES NOUVELLES SUR LES HEPATITES OBSERVEES AU COURS DES TRAITEMENTS ANTITUBERCULEUX INCLUANT LA RIFAMPICINEEMERIT J; DECROIX G; CHOMETTE G et al.1974; REV. FR. MAL. RESP.; FR.; DA. 1974; VOL. 2; NO 6-7; PP. 565-584; ABS. ANGL.; BIBL. 3P.1/2Article

Hépatites dues aux nouveaux anti-inflammatoires non stéroïdiens = Hepatitis due to new non-steroidal anti-inflammatory drugsBABANY, G; PESSAYRE, D.Gastroentérologie clinique et biologique. 1984, Vol 8, Num 6-7, pp 523-529, issn 0399-8320Article

EFFECTS OF TROLEANDOMYCIN ADMINISTRATION ON CHOLESTEROL 7ALPHA -HYDROXYLASE ACTIVITY AND BILE SECRETION IN RATSLE DAFNIET M; PESSAYRE D; LE QUERNEC L et al.1981; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1981; VOL. 219; NO 2; PP. 558-562; BIBL. 27 REF.Article

PROPRANOLOL DOES NOT FURTHER DECREASE THE CLEARANCE OF ANTIPYRINE IN PATIENTS WITH ALCOHOLIC CIRRHOSISLARREY D; LEBREC D; BERCOFF E et al.1983; CLINICAL SCIENCE (1979); ISSN 0143-5221; GBR; DA. 1983; VOL. 65; NO 2; PP. 203-205; BIBL. 13 REF.Article

MECHANISM FOR REDUCED DRUG CLEARANCE IN PATIENTS WITH CIRRHOSIS.PESSAYRE D; LEBREC D; DESCATOIRE V et al.1978; GASTROENTEROLOGY; U.S.A.; DA. 1978; VOL. 74; NO 3; PP. 566-571; BIBL. 24 REF.Article

Stéatoses, phospholipidoses, et lésions pseudo-alcooliques hépatiques d'origine médicamenteuse = Drug-induced steatosis, phospholipidosis and alcohol-like liver injuryFRENEAUX, E; PESSAYRE, D.Gastroentérologie clinique et biologique. 1993, Vol 17, Num 5BIS, pp H36-H43, issn 0399-8320Article

IN SITU FORMATION OF THE ACETAMINOPHEN METABOLITE COVALENTLY BOUND IN KIDNEY AND LUNG SUPPORTIVE EVIDENCE PROVIDED BY TOTAL HEPATECTOMYBREEN K; WANDSCHEER JC; PEIGNOUX M et al.1982; BIOCHIM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 1; PP. 115-116; BIBL. 9 REF.Article

EFFECTS OF INDUCERS ON THE IN VIVO COVALENT BINDING OF A VINYL CHLORIDE METABOLITE TO LIVER FRACTIONSPESSAYRE D; WANDSCHEER JC; DESCATOIRE V et al.1979; BIOCHEM. PHARMACOL.; GBR; DA. 1979; VOL. 28; NO 24; PP. 3667-3668; BIBL. 17 REF.Article